Skip to main content

Urology · UK

PCNL - is it the right call for your stone?

Three treatments compete for every kidney stone: PCNL, ureteroscopy and shockwave. Which one wins depends on four facts sitting on your CT scan - size, density, position and anatomy. We run that comparison honestly, then arrange whichever treatment it points to.

A radiographer guides a patient onto the bed of an advanced 3 Tesla MRI scanner in a London imaging suite

Indicative pricing

What each stone treatment costs in the UK.

Side-by-side ranges across our partner stone units - because the comparison is incomplete without the money.

In short

Compare the whole journey, not the session - one PCNL can undercut three shockwave visits plus a rescue.

Treatment route Indicative range
PCNL (standard or mini) - all-in £7,500–£12,500
Flexible ureteroscopy and laser - all-in £5,000–£8,500
Shockwave lithotripsy (ESWL) - per session £1,500–£2,500
Staghorn or multi-tract PCNL - all-in £11,000–£16,000
CT KUB with specialist stone review £400–£700
Stone-treatment decision consultation £250–£400

Per-session prices flatter the less definitive options: a large stone booked for shockwave typically needs two or three sessions, sometimes a stent, and occasionally surgical rescue - at which point the gentle route has cost more than the decisive one. Our quotes always project the likely total for your specific stone, so the comparison is real.

The problem

Stone treatment is a decision before it is a procedure.

Most stone regret traces back to the fork in the road, not the operating table - the wrong modality chosen for reasons that had nothing to do with the stone.

  • Equipment bias is real

    A clinic with a lithotripter fills its lithotripter. The safeguard is advice from someone with no machine to feed - which is precisely what we are.

  • The CT answers most of it

    Size over 2 cm, density over 1,000 HU, a lower-pole position - each is a fact, not an opinion. We make sure the facts are extracted before preferences enter.

  • Indecision has a price

    Months of pinballing between options means months of infections, colic and quiet kidney damage. A clear comparison, made once, ends the drift.

The journey

From scan to settled decision - what happens, in order.

One team from first message through the comparison, whichever treatment wins it, and the prevention work afterwards.

  1. 01

    Before

    A short, confidential form plus any imaging reports you have. No CT yet?

  2. 02

    Before

  3. 03

    Before

    You meet a surgeon who does all of them

    A consultation with an endourologist whose practice spans every modality, so the plan survives scrutiny rather than reflecting a favourite instrument.

  4. 04

    Before

    Work-up for the chosen route

    If PCNL wins: urine culture, anaesthetic review, blood group and tract planning. If a lesser option wins on merit, the work-up is correspondingly lighter - one advantage worth having.

  5. 05

    On the day

    Treatment day

    PCNL means a general anaesthetic, a 1 cm flank incision and one to three nights in. Ureteroscopy is usually a day-case GA. Shockwave needs no anaesthetic at all. The choice you made shapes the day entirely.

  6. 06

    On the day

    Immediate aftermath

    Whatever the route, you leave knowing what was cleared, what drains or stents are in, and exactly which symptoms would mean calling the team.

  7. 07

    After

    Clearance imaging and the recurrence plan

    A scan at four to six weeks answers the only question that matters - is the kidney clear? Then stone analysis and a metabolic screen, because half of stone-formers otherwise do this again.

Typical decision-to-treatment: 2–4 weeks. The comparison itself: one working day once we have your CT.

Which stone, which treatment

How the facts of your stone settle the question.

The scenarios that decide between PCNL and its rivals, plus the one that is an emergency rather than a decision.

  • Stone over 2 cm - PCNL wins

    Above 2 cm, guidelines are unambiguous: PCNL clears in one operation what other methods chip at across multiple sessions.

  • Stone 1–2 cm - genuinely arguable

    The contested middle ground. Position, density and your priorities decide between ureteroscopy and PCNL - this is where independent advice earns its keep.

  • Stone under 1 cm - usually not PCNL

    Ureteroscopy or shockwave almost always serves better. Anyone offering PCNL for a 7 mm stone should be asked why, twice.

  • Dense stone on CT

    Above roughly 1,000 Hounsfield units, shockwave fragmentation falters. Density pushes the decision towards a scope or a tract.

  • Lower-pole location

    Gravity works against fragment clearance from the lower pole. Shockwave results sag; PCNL and ureteroscopy hold up.

  • One kidney, or reduced function

    When there is no spare, the calculus changes - maximum clearance per anaesthetic argues for the definitive option, planned meticulously.

  • Anticoagulated patients

    Blood thinners reshape the choice: ureteroscopy can often proceed on them; PCNL and shockwave cannot. Sometimes the drug decides the treatment.

  • Red flag: sepsis signs with a known stone

    Fever, rigors or confusion with a stone in place is an obstructed, infected kidney until proven otherwise - 999 or A&E, not a treatment-comparison exercise.

The comparison

Three treatments, five ways to judge them.

The contenders, then the criteria that actually separate them - clearance, invasiveness, sessions, risk profile and your personal circumstances.

  • PCNL - the heavyweight

    Direct tract into the kidney, stone removed under vision. Highest single-session clearance for big stones; the price is a GA, a hospital stay and the bleeding risk.

  • Ureteroscopy - the all-rounder

    A flexible scope up the natural passages, laser fragmentation, day-case. Best for stones under 2 cm and reachable positions; often repeatable without drama.

  • Shockwave - the gentle option

    Focused sound waves from outside, no anaesthetic. Right for small, soft, well-placed stones - and honest about its limits everywhere else.

  • Judge them on: clearance

    For a 2.5 cm stone: PCNL near 90 percent in one sitting; ureteroscopy perhaps 60–70 percent needing staged returns; shockwave far behind. For 8 mm: the ranking flips.

  • Judge them on: invasiveness

    Shockwave, ureteroscopy, PCNL - in strictly ascending order of anaesthetic, instrumentation and stay. The right choice spends invasiveness only where it buys clearance.

  • Judge them on: sessions and time off

    One PCNL with four to six weeks of recovery can cost less total disruption than three shockwave visits, a stent, and a mop-up ureteroscopy. Count the whole journey.

  • Judge them on: risk profile

    PCNL carries the bleeding and organ-injury risks; ureteroscopy carries ureteric injury and stent symptoms; shockwave carries bruising and steinstrasse. None is free.

  • Judge them on: your circumstances

    Anticoagulants, solitary kidney, obesity, pacemakers, pregnancy - each moves the needle. The comparison is personal or it is worthless.

Safety, compared

How the risks stack up across the options - honestly.

Each modality carries its own risk profile - and so does choosing the wrong one. The safest treatment is the one your stone actually needs.

  • The comparison is a safety decision

    Choosing PCNL for a stone that needed it is safer than three failed alternatives followed by PCNL anyway. Under-treatment has a complication rate too - it is just deferred.

  • PCNL risks, in brief

    Transfusion 3–7 percent, sepsis 1–3 percent, organ injury under 1 percent, plus a GA and one to three nights in hospital. Our procedure-walkthrough page covers each in depth.

  • Ureteroscopy risks, in brief

    Stent symptoms in most, urinary infection in a few percent, ureteric injury rarely. Staged procedures are common for larger stones - plan for the possibility.

  • Shockwave risks, in brief

    Flank bruising, blood in the urine for a day or two, renal colic as fragments pass, and steinstrasse - a queue of fragments blocking the ureter - occasionally needing rescue.

  • Every option needs clearance imaging

    A treatment is not finished until a scan says the kidney is clear.

  • Infection screening applies across the board

    Infected urine turns any stone intervention into a sepsis risk. Culture first, treat first - whichever modality wins the comparison.

  • Anaesthetic exposure differs sharply

    Shockwave: none. Ureteroscopy: usually one day-case GA. PCNL: one longer GA. For frail patients this axis alone can settle the decision.

  • Waiting has a cost too

    A large stone left while ESWL sessions accumulate keeps causing infections and quietly eroding function. Decisiveness is part of safety.

  • Red flags after any stone treatment

    Fever or rigors, uncontrolled pain, persistent heavy bleeding or inability to pass urine - the treating team or A&E the same day, whichever treatment you had.

Reading your treatment plan

Your treatment plan in four parts. Read the last one first.

Whichever route wins the comparison, the plan and notes you receive keep to the same shape.

A UK consultant reviewing a patient’s kidney stone treatment plan

A quiet reminder

Hounsfield units and calyces are not everyday language - we translate them for you.

If you would like us to walk you through your CT findings and what they mean for each option, just ask.

  1. 01 Header

    The stone, measured and mapped

    Size, density, location and the state of the kidney behind it - the four facts your CT contributed to the decision.

  2. 02 Technique

    The options as they applied to you

    How each modality scored for your stone - expected clearance, sessions, downtime - and why the recommendation landed where it did.

  3. 03 Findings

    What treatment actually achieved

    Clearance at surgery or after the session, anything staged or deferred, and the fragments sent for analysis.

  4. 04 Impression

    Clearance scan and prevention plan

    Read this first: the follow-up imaging date, stent arrangements if any, and the metabolic work-up that cuts the odds of a rematch.

Recognised by major UK insurers

BupaAXA HealthVitalityAvivaWPACignaHealixBupaAXA HealthVitalityAvivaWPACignaHealixBupaAXA HealthVitalityAvivaWPACignaHealix

All three stone treatments are routinely covered when medically indicated. Insurers occasionally query repeated shockwave sessions - one more argument for getting the modality right first time. We pre-authorise before booking.

Frequently asked

Everything we get asked when choosing stone treatment.

Quick answers on when PCNL wins, when it does not, how the costs compare and what the NHS would do.

  • How do I know if my kidney stone needs PCNL?

    Size is the first filter: stones over 2 cm, staghorn stones, and lower-pole stones over 1 cm are classic PCNL territory. Density and position refine it - very hard stones and awkward locations push towards PCNL even at smaller sizes. The honest answer lives on your CT scan, which is why we have it reviewed by a stone specialist before anyone talks you into anything.

  • Why not just have shockwave - it seems so much easier?

    For the right stone, shockwave is wonderful: no anaesthetic, no incision, home in an hour. For the wrong stone - large, dense, lower-pole - it delivers repeated sessions, repeated fragment passage, stents, and often PCNL at the end anyway. Easier per session is not easier overall. The comparison has to be run per stone, not per brochure.

  • What is the difference between PCNL and ureteroscopy?

    Ureteroscopy reaches the stone from inside, passing a flexible scope up the bladder and ureter - no incision, usually a day-case. PCNL reaches it from outside, through a 1 cm tract in your flank directly into the kidney - a bigger undertaking with an overnight stay, but with far higher one-session clearance for large stones. Under about 1.5–2 cm the scope usually wins; above it, the tract does.

  • How do the costs compare privately in the UK?

    As 2026 all-in figures: shockwave £1,500–£2,500 per session (larger stones typically need two or three), ureteroscopy with laser £5,000–£8,500, and PCNL £7,500–£12,500, rising to £16,000 for staghorn cases. Deceptively, the cheapest option per session can be the dearest per cleared kidney - we always quote the projected whole-journey cost for each route.

  • What would happen on the NHS?

    The same decision framework applies - NICE and European guidance are what NHS urologists follow too - and all three treatments are available. The differences are waiting time, which for non-emergency stone surgery commonly runs months, and less choice over which consultant and which modality-mix unit you land in. Many patients use us for a fast independent opinion, then decide between NHS and private treatment with clear eyes.

  • Can a large stone just be left and watched?

    Rarely wisely. Large stones do not dissolve; they grow, harbour infection and erode kidney function - often silently. Watchful waiting has a place for small, symptom-free stones, but a stone big enough to raise the PCNL question is almost always a stone big enough to treat. If a genuine watch-and-wait case comes to us, we say so and charge nothing.